Concepedia

Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism

Iraj Nabipour, Mohammadreza Kalantarhormozi, Majid Assadi, Seyed Mojtaba Jafari, Mohammad Gharibi, Esmaeil Ahmadi, Zahra Sanjdideh

Endocrine · 2010 · 10 citations · 28 references

DOI

Concepts

References

28

Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule

Jianhua Cheng, Tong Zhou, Changdan Liu et al. · Science · 1994 · 1.1K citations

, , +17

Metalloproteinase-mediated release of human Fas ligand.

Nobuhiko Kayagaki, Tomohiko Ebata, Hiroshi Ohmoto et al. · The Journal of Experimental Medicine · 1995 · 831 citations · Full text

, , +15

Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity

Pascal Schneider, Nils Holler, Jean-Luc Bodmer et al. · The Journal of Experimental Medicine · 1998 · 803 citations · Full text

, , +16

Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing

Takashi Suda, Hideo Hashimoto, Masato Tanaka et al. · The Journal of Experimental Medicine · 1997 · 509 citations · Full text

, , +14

A Population-Based Study of Chronic Autoimmune Hypothyroidism in Danish Twins<sup>1</sup>

Thomas Heiberg Brix, Kirsten Ohm Kyvik, Laszlo Hegedüs · The Journal of Clinical Endocrinology & Metabolism · 2000 · 210 citations · Full text

, , +13